CARULLO, MARTINA
 Distribuzione geografica
Continente #
EU - Europa 114
NA - Nord America 101
AS - Asia 88
AF - Africa 16
Totale 319
Nazione #
US - Stati Uniti d'America 100
IT - Italia 89
SG - Singapore 56
CN - Cina 25
CI - Costa d'Avorio 9
SE - Svezia 8
SN - Senegal 7
DE - Germania 6
PL - Polonia 5
IN - India 4
AT - Austria 3
KR - Corea 3
FI - Finlandia 2
CA - Canada 1
GB - Regno Unito 1
Totale 319
Città #
Singapore 29
Boardman 16
New York 16
Pisa 15
Florence 14
Santa Clara 13
Abidjan 9
Ashburn 8
Milan 8
Dakar 7
Genoa 6
Ogden 5
Quanzhou 5
Warsaw 5
Fuzhou 4
Hyderabad 4
Los Angeles 4
Munich 4
Salerno 4
Shanghai 4
Cascina 3
Nam-gu 3
Rome 3
Turin 3
Vienna 3
Castelvetro di Modena 2
Castiglione Chiavarese 2
Center 2
Fano 2
Phoenix 2
Taranto 2
Washington 2
York 2
Billings 1
Cologne 1
Dallas 1
Fort Worth 1
Gargallo 1
Guangzhou 1
Kent 1
Lappeenranta 1
Montereale Valcellina 1
Pistoia 1
Taiyuan 1
Toronto 1
Vicopisano 1
Wuhan 1
Xiamen 1
Totale 226
Nome #
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials 43
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 37
Surgery combined with intra-operative microwaves ablation for the management of colorectal cancer liver metastasis: A case-matched analysis and evaluation of recurrences 33
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm 30
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 29
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study 28
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability 26
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials 24
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials 21
The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients 17
null 15
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 14
ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer 10
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence 10
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies 10
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 7
Totale 354
Categoria #
all - tutte 2.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202352 0 0 0 0 0 15 0 2 22 0 12 1
2023/2024186 6 10 18 9 19 24 26 4 12 13 24 21
2024/2025116 18 26 13 33 26 0 0 0 0 0 0 0
Totale 354